Choosing the right strategy for the management of patients with relapsed CLL

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on how these new data could impact current clinical practice.

Learning objective:

After participating in this session delegates should be able to:

• Appraise the available treatment strategies for patients with relapsed CLL

Faculty:

• Peter Hillmen (UK)
• Steven Coutré (USA)
• Carol Moreno (Spain)
• Ulrich Jäger (Austria)
• Gianluca Gaidano (Italy)